Cell therapy companies make strong progress from October 2012 to March 2013 amid mixed stock market sentiment.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 23746973.
- Also identified by DOI 10.1016/j.stem.2013.05.017.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
During Q4 2012 and Q1 2013, the cell therapy industry made strong progress in translation and commercialization. Continued development of the companies included in a dedicated stock market index suggests emergence of this industry as a distinct healthcare sector.
Medical subject headings
- Investments
- Stem Cell Research
- Stem Cell Transplantation